BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21683848)

  • 1. The Gordian knot of revascularization for multivessel coronary artery disease.
    Takagi H; Manabe H; Umemoto T
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):241-2; author reply 242-3. PubMed ID: 21683848
    [No Abstract]   [Full Text] [Related]  

  • 2. To excel or to confirm? That is the question.
    Dangas G
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):944. PubMed ID: 21598346
    [No Abstract]   [Full Text] [Related]  

  • 3. Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.
    Delhaye C; Sudre A; Lemesle G; Vanesson L; Koussa M; Fayad G; Bauters C; Lablanche JM; Modine T
    Arch Cardiovasc Dis; 2010 Oct; 103(10):502-11. PubMed ID: 21130963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I indications for coronary artery bypass graft surgery: what is the appropriate therapy for patients with multivessel coronary disease?
    Dean LS
    JACC Cardiovasc Interv; 2009 Jul; 2(7):622-3. PubMed ID: 19628184
    [No Abstract]   [Full Text] [Related]  

  • 5. It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):949-50. PubMed ID: 21108371
    [No Abstract]   [Full Text] [Related]  

  • 6. Left main and high-risk PCI: what, exactly, is it high risk for?
    Safian RD
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
    [No Abstract]   [Full Text] [Related]  

  • 7. DES in SVGs: safe and at least short-term effective.
    Hillegass WB
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):356-7. PubMed ID: 21328680
    [No Abstract]   [Full Text] [Related]  

  • 8. More openness and a little less strut: two good ideas for stents and the people who implant them.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
    [No Abstract]   [Full Text] [Related]  

  • 9. Time for coronary artery bypass grafting to make a comeback?
    Taggart D
    Semin Thorac Cardiovasc Surg; 2011; 23(1):5-7. PubMed ID: 21807289
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-eluting stent implantation for the treatment of cardiac transplant vasculopathy: the jury is still out.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):970-1. PubMed ID: 21598349
    [No Abstract]   [Full Text] [Related]  

  • 11. Each generation improves on the last (in cardiology): Bayesian thinking, the randomized clinical trial, and directed evolution.
    Morrison DA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1018-9. PubMed ID: 21598353
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies.
    Yan TD; Padang R; Poh C; Cao C; Wilson MK; Bannon PG; Vallely MP
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1134-44. PubMed ID: 21167508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for patients with left main coronary artery disease.
    Lee MS; Nguyen J
    Rev Cardiovasc Med; 2011; 12(2):e77-83. PubMed ID: 21796086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 15. Validating the EXCEL hypothesis: a propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32.
    Capodanno D; Caggegi A; Capranzano P; Cincotta G; Miano M; Barrano G; Monaco S; Calvo F; Tamburino C
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):936-43. PubMed ID: 21547994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et al.
    Marx N
    Diab Vasc Dis Res; 2011 Apr; 8(2):173. PubMed ID: 21562069
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary artery disease: revascularization strategies for patients with CAD and diabetes.
    Myers GR; Weintraub WS
    Nat Rev Cardiol; 2010 Jul; 7(7):364-6. PubMed ID: 20577296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left main stenting: do we need another study?
    Lemos PA; Kappetein P; Kalil-Filho R; Jatene FB
    EuroIntervention; 2010 Dec; 6 Suppl J():J118-22. PubMed ID: 21930475
    [No Abstract]   [Full Text] [Related]  

  • 19. Additional data supporting the safety and effectiveness of unprotected left main interventions.
    Shannon J; Colombo A
    EuroIntervention; 2011 Oct; 7(6):653-7. PubMed ID: 21986323
    [No Abstract]   [Full Text] [Related]  

  • 20. The Slauson cutoff and peri-operative risk for abdominal vascular surgery.
    Butman SM
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):142-3. PubMed ID: 21181974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.